Latest / Cleveland Clinic Cancer Advances
The Potential of CAR T-Cell Therapy for Chronic Lymphocytic Leukemia (CLL)
Vice Chair of the Center for Immunotherapy & Precision Immuno-Oncology, J. Joseph Melenhorst, PhD, joins the Cancer Advances Podcast to discuss the potential of CAR T-cell therapy for chronic lymphocytic leukemia (CLL). Listen as Dr. Melenhorst explains how advancements in cell therapy are overcoming challenges like T cell exhaustion, improving response rates, and how novel approaches could improve treatment outcomes.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.